Antiviral Agent for Preventing or Treating COVID-19
The Kitasato Institute
Director-General of the National Institute of Health Sciences
Matsuyama University
Tokiwa Phytochemical Co., Ltd.
Tsumura & Co.
Tsutomu Shimada, Jinwei Yang, Yuka Koike
JP 7214080
2021. 10. 1
2023. 1. 20
The present invention relates to an antiviral agent that can be used to prevent or treat COVID-19 and comprises, as an active ingredient, Ephedra Herb extract, ephedrine alkaloids-free Ephedra Herb extract (EFE) obtainable by removing ephedrine alkaloids from Ephedra Herb extract, and/or macromolecule condensed tannins obtained from Ephedra Herb extract and EFE.